0001752724-20-067404.txt : 20200331 0001752724-20-067404.hdr.sgml : 20200331 20200331131405 ACCESSION NUMBER: 0001752724-20-067404 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200131 FILED AS OF DATE: 20200331 PERIOD START: 20201031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AIM INTERNATIONAL MUTUAL FUNDS (INVESCO INTERNATIONAL MUTUAL FUNDS) CENTRAL INDEX KEY: 0000880859 IRS NUMBER: 760352823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-06463 FILM NUMBER: 20760795 BUSINESS ADDRESS: STREET 1: 11 GREENWAY PLAZA STREET 2: SUITE 1000 CITY: HOUSTON STATE: TX ZIP: 77046 BUSINESS PHONE: 7136261919 MAIL ADDRESS: STREET 1: 11 GREENWAY PLAZA STREET 2: SUITE 1000 CITY: HOUSTON STATE: TX ZIP: 77046 FORMER COMPANY: FORMER CONFORMED NAME: AIM INTERNATIONAL MUTUAL FUNDS DATE OF NAME CHANGE: 20031126 FORMER COMPANY: FORMER CONFORMED NAME: AIM INTERNATIONAL FUNDS INC /MD/ DATE OF NAME CHANGE: 20000620 FORMER COMPANY: FORMER CONFORMED NAME: AIM INTERNATIONAL MUTUAL FUNDS DATE OF NAME CHANGE: 20000323 0000880859 S000064625 Invesco Oppenheimer Global Opportunities Fund C000209211 Class R5 C000209212 Class R6 C000209213 Class Y C000209214 Class A C000209215 Class C C000209216 Class R NPORT-P 1 primary_doc.xml NPORT-P false 0000880859 XXXXXXXX S000064625 C000209215 C000209214 C000209212 C000209213 C000209211 C000209216 AIM International Mutual Funds (Invesco International Mutual Funds) 811-06463 0000880859 549300CGSTEJJ7H1ET84 11 Greenway Plaza Suite 1000 Houston 77046-1173 800-959-4246 Invesco Oppenheimer Global Opportunities Fund S000064625 549300TQY3T0I6C0EN92 2020-10-31 2020-01-31 N 7476395460.3 8109587.74 7468285872.56 0 0 0 0 0 0 0 0 0 0 0 0 0 0 N QUALCOMM, Inc. H1J8DDZKZP6H7RWC0H53 QUALCOMM, Inc. 747525103 2000000.00000000 NS USD 170620000.00000000 2.284593853415 Long EC CORP US N 1 N N N Flutter Entertainment PLC 635400EG4YIJLJMZJ782 Flutter Entertainment PLC N/A 400000.00000000 NS 45404135.01000000 0.607959253097 Long EC CORP IE N 2 N N N M&C Saatchi PLC 213800XBLFQZ1T1KBA87 M&C Saatchi PLC N/A 6600000.00000000 NS 8681222.10000000 0.116241159593 Long EC CORP GB N 2 N N N Coherent, Inc. 549300RYOCKUMWACR010 Coherent, Inc. 192479103 600000.00000000 NS USD 84858000.00000000 1.136244667759 Long EC CORP US N 1 N N N Manhattan Associates, Inc. 529900Q1GJP7KD52SW51 Manhattan Associates, Inc. 562750109 600000.00000000 NS USD 51276000.00000000 0.686583251832 Long EC CORP US N 1 N N N PTC, Inc. 54930050SSMU8SKDJ030 PTC, Inc. 69370C100 1200000.00000000 NS USD 99744000.00000000 1.335567514447 Long EC CORP US N 1 N N N Disco Corp. N/A Disco Corp. N/A 200000.00000000 NS 46293795.03000000 0.619871759329 Long EC CORP JP N 2 N N N Yaskawa Electric Corp. 3538003K39GR98R0CK58 Yaskawa Electric Corp. N/A 2000000.00000000 NS 68776842.32000000 0.920918715400 Long EC CORP JP N 2 N N N PVA TePla AG 5299002Y7DARXV2Y4R82 PVA TePla AG N/A 2050000.00000000 NS 33869819.66000000 0.453515307768 Long EC CORP DE N 2 N N N Illumina, Inc. SQ95QG8SR5Q56LSNF682 Illumina, Inc. 452327109 200000.00000000 NS USD 58014000.00000000 0.776804758012 Long EC CORP US N 1 N N N Nidec Corp. 353800IF171MZTNL6Y31 Nidec Corp. N/A 300000.00000000 NS 37977697.90000000 0.508519606079 Long EC CORP JP N 2 N N N AO World PLC 2138005FFOAJIUZY4375 AO World PLC N/A 20000000.00000000 NS 20124972.10000000 0.269472439103 Long EC CORP GB N 2 N N N Optex Group Co., Ltd. N/A Optex Group Co., Ltd. N/A 2000000.00000000 NS 26513937.89000000 0.355020393466 Long EC CORP JP N 2 N N N Frontier Developments PLC 213800B9LGPWUAZ9GX18 Frontier Developments PLC N/A 3000000.00000000 NS 55963275.58000000 0.749345653540 Long EC CORP GB N 2 N N N Teleperformance 9695004GI61FHFFNRG61 Teleperformance N/A 300000.00000000 NS 75400417.34000000 1.009608076426 Long EC CORP FR N 2 N N N Brembo S.p.A. 549300BLWVJN2BAT0A44 Brembo S.p.A. N/A 2000000.00000000 NS 22856124.12000000 0.306042437448 Long EC CORP IT N 2 N N N Biocartis N.V. N/A Biocartis N.V. BA5566282 6000000.00000000 NS 37836246.62000000 0.506625580027 Long EC CORP BE Y 2 N N N Rite Aid Corp. 529900W353T1JY1DKT44 Rite Aid Corp. 767754872 2500000.00000000 NS USD 29875000.00000000 0.400024858579 Long EC CORP US N 1 N N N Rollins, Inc. 549300F2A0BXT4SGWD84 Rollins, Inc. 775711104 1500000.00000000 NS USD 56925000.00000000 0.762223098732 Long EC CORP US N 1 N N N Invesco Government & Agency Portfolio 5493007T1J7WZ5QI1A47 Invesco Government & Agency Portfolio, Institutional Class 825252885 212460340.82000000 NS USD 212460340.82000000 2.844834068291 Long STIV RF US N 1 N N N Umicore S.A. 529900F3AIQECS8ZSV61 Umicore S.A. N/A 600000.00000000 NS 27640834.09000000 0.370109481100 Long EC CORP BE N 2 N N N Nevro Corp. 254900SH91I4BOYKUE38 Nevro Corp. 64157F103 1000000.00000000 NS USD 132910000.00000000 1.779658709749 Long EC CORP US N 1 N N N Corning, Inc. 549300X2937PB0CJ7I56 Corning, Inc. 219350105 1000000.00000000 NS USD 26690000.00000000 0.357377856919 Long EC CORP US N 1 N N N Twitter, Inc. 549300I8RX485XMK6836 Twitter, Inc. 90184L102 2000000.00000000 NS USD 64960000.00000000 0.869811374503 Long EC CORP US N 1 N N N boohoo Group PLC 213800SZF3KFCECWY243 boohoo Group PLC N/A 30000000.00000000 NS 119708077.10000000 1.602885576994 Long EC CORP JE N 2 N N N Rovio Entertainment Oyj 743700H95H3OPXDV6568 Rovio Entertainment Oyj N/A 4700000.00000000 NS 23630761.60000000 0.316414797227 Long EC CORP FI Y 2 N N N Cree, Inc. 549300OGU88P3AW3TO93 Cree, Inc. 225447101 1000000.00000000 NS USD 46490000.00000000 0.622498934739 Long EC CORP US N 1 N N N Technicolor S.A. 4N6SD705LP5XZKA2A097 Technicolor S.A. N/A 29700000.00000000 NS 20605836.04000000 0.275911184863 Long EC CORP FR N 2 N N N PDF Solutions, Inc. 549300GMSP6MROFBI160 PDF Solutions, Inc. 693282105 3000000.00000000 NS USD 47280000.00000000 0.633076997945 Long EC CORP US N 1 N N N Novozymes A/S 529900T6WNZXD2R3JW38 Novozymes A/S, Class B N/A 1000000.00000000 NS 52195618.81000000 0.698896904867 Long EC CORP DK N 2 N N N Adevinta ASA 529900W8V3YLHRSZH763 Adevinta ASA, Class B N/A 900000.00000000 NS 10942007.62000000 0.146512972410 Long EC CORP NO N 2 N N N ON Semiconductor Corp. ZV20P4CNJVT8V1ZGJ064 ON Semiconductor Corp. 682189105 2000000.00000000 NS USD 46300000.00000000 0.619954843588 Long EC CORP US N 1 N N N Cloudera, Inc. 549300PGONC4JOI0RG62 Cloudera, Inc. 18914U100 8220000.00000000 NS USD 84583800.00000000 1.132573142530 Long EC CORP US N 1 N N N PeptiDream, Inc. N/A PeptiDream, Inc. N/A 3000000.00000000 NS 142619302.85000000 1.909665822702 Long EC CORP JP N 2 N N N Hansa Biopharma AB 549300LLEO25ZJJ3NT91 Hansa Biopharma AB N/A 1938841.00000000 NS 14470610.26000000 0.193760797416 Long EC CORP SE N 2 N N N Advanced Micro Devices, Inc. R2I72C950HOYXII45366 Advanced Micro Devices, Inc. 007903107 14000000.00000000 NS USD 658000000.00000000 8.810589353811 Long EC CORP US N 1 N N N Ion Beam Applications S.A. 5493002RVRZ1S3CPUI26 Ion Beam Applications S.A. N/A 400000.00000000 NS 4606316.04000000 0.061678357237 Long EC CORP BE N 2 N N N Arrowhead Pharmaceuticals, Inc. 549300O3CSB8T7OZ3D66 Arrowhead Pharmaceuticals, Inc. 04280A100 3000000.00000000 NS USD 125730000.00000000 1.683518844156 Long EC CORP US N 1 N N N EVR Holdings PLC 213800B2AKGQC3D2R751 EVR Holdings PLC N/A 68750000.00000000 NS 4041901.44000000 0.054120872031 Long EC CORP GB N 2 N N N IG Group Holdings PLC 2138003A5Q1M7ANOUD76 IG Group Holdings PLC N/A 3000000.00000000 NS 26284545.27000000 0.351948836969 Long EC CORP GB N 2 N N N Xvivo Perfusion AB 549300G2464FYLS14B41 Xvivo Perfusion AB N/A 1000000.00000000 NS 18114128.95000000 0.242547342979 Long EC CORP SE N 2 N N N Carl Zeiss Meditec AG 529900GRL4MZ8NMOOK95 Carl Zeiss Meditec AG, BR N/A 800000.00000000 NS 98085663.43000000 1.313362465012 Long EC CORP DE N 2 N N N Shake Shack, Inc. 529900J74GJAHYP80N79 Shake Shack, Inc., Class A 819047101 1000000.00000000 NS USD 67450000.00000000 0.903152358532 Long EC CORP US N 1 N N N MorphoSys AG 529900493806K77LRE72 MorphoSys AG N/A 700000.00000000 NS 87671135.21000000 1.173912417200 Long EC CORP DE N 2 N N N Aston Martin Lagonda Global Holdings PLC 213800167WOVOK5ZC776 Aston Martin Lagonda Global Holdings PLC N/A 20500000.00000000 NS 135493297.80000000 1.814248946974 Long EC CORP GB Y 2 N N N Rothschild & Co. SCS 549300ILF3L0BBIDPZ11 Rothschild & Co. SCS N/A 229756.00000000 NS 6176075.40000000 0.082697361956 Long EC CORP FR N 2 N N N IQE PLC 213800Y33WHD3ESJJP16 IQE PLC N/A 140000000.00000000 NS 94722014.98000000 1.268323368927 Long EC CORP GB N 2 N N N Allied Minds PLC 213800YB4G7YN21NLL72 Allied Minds PLC N/A 10000000.00000000 NS 4850605.25000000 0.064949378381 Long EC CORP GB N 2 N N N Veeco Instruments, Inc. 5493004201F72ADDZW04 Veeco Instruments, Inc. 922417100 4000000.00000000 NS USD 51000000.00000000 0.682887624687 Long EC CORP US N 1 N N N Recipharm AB 549300FHCTIFJOZ9D484 Recipharm AB, Class B N/A 2000000.00000000 NS 29315931.82000000 0.392538961687 Long EC CORP SE N 2 N N N AIXTRON S.E. 5299004UJ4D51M25LD67 AIXTRON S.E. N/A 4000000.00000000 NS 42381586.23000000 0.567487465707 Long EC CORP DE N 2 N N N First Solar, Inc. 549300NPYMLM4NHTOF27 First Solar, Inc. 336433107 2000000.00000000 NS USD 99160000.00000000 1.327747781647 Long EC CORP US N 1 N N N Xeris Pharmaceuticals, Inc. 5493001EPAB2LX05WW18 Xeris Pharmaceuticals, Inc. 98422L107 1000000.00000000 NS USD 6370000.00000000 0.085294003318 Long EC CORP US N 1 N N N IP Group PLC 213800HG22UM138WFG43 IP Group PLC N/A 20785545.00000000 NS 19049145.90000000 0.255067176391 Long EC CORP GB N 2 N N N Bang & Olufsen A/S 52990018KGR3ILFDNJ20 Bang & Olufsen A/S N/A 2000000.00000000 NS 11974466.53000000 0.160337549128 Long EC CORP DK N 2 N N N Indutrade AB 549300FISLQ6CEFP1867 Indutrade AB N/A 2000000.00000000 NS 71934341.07000000 0.963197476603 Long EC CORP SE N 2 N N N M3, Inc. N/A M3, Inc. N/A 4000000.00000000 NS 117223512.34000000 1.569617370576 Long EC CORP JP N 2 N N N Zendesk, Inc. 549300SLI6BN94BKKO36 Zendesk, Inc. 98936J101 600000.00000000 NS USD 51840000.00000000 0.694135185564 Long EC CORP US N 1 N N N Applied Materials, Inc. 41BNNE1AFPNAZELZ6K07 Applied Materials, Inc. 038222105 1000000.00000000 NS USD 57990000.00000000 0.776483399130 Long EC CORP US N 1 N N N Comture Corp. N/A Comture Corp. N/A 3000000.00000000 NS 58593256.68000000 0.784560977978 Long EC CORP JP N 2 N N N Amplifon S.p.A. ZYXJDNVM2JI3VBM8G556 Amplifon S.p.A. N/A 1000000.00000000 NS 28371937.50000000 0.379898921708 Long EC CORP IT N 2 N N N Nektar Therapeutics 5299005I24806IOIYE03 Nektar Therapeutics 640268108 31300000.00000000 NS USD 622557000.00000000 8.336009234560 Long EC CORP US N 1 N N N Blue Prism Group plc 2138006DQE9FNUW8KO83 Blue Prism Group plc N/A 3000000.00000000 NS 69206691.24000000 0.926674372418 Long EC CORP GB N 2 N N N ASOS PLC 213800H8DBB8JSKDW630 ASOS PLC G0536Q108 700000.00000000 NS 28386040.86000000 0.380087765042 Long EC CORP GB N 2 N N N Zoo Digital Group PLC 213800377KWAPKN5HX30 Zoo Digital Group PLC N/A 7000000.00000000 NS 6697321.63000000 0.089676824699 Long EC CORP GB N 2 N N N First Derivatives PLC 213800MKQAJ5R7WIU633 First Derivatives PLC N/A 1200000.00000000 NS 43942486.42000000 0.588387846553 Long EC CORP GB N 2 N N N Eurofins Scientific S.E. 529900JEHFM47DYY3S57 Eurofins Scientific S.E. N/A 300000.00000000 NS 161628271.00000000 2.164195020893 Long EC CORP LU N 2 N N N Beijer Ref AB 549300PZZEUVH08H4G75 Beijer Ref AB N/A 2000000.00000000 NS 60117591.33000000 0.804971747946 Long EC CORP SE N 2 N N N Continental AG 529900A7YD9C0LLXM621 Continental AG N/A 100000.00000000 NS 11436979.81000000 0.153140626981 Long EC CORP DE N 2 N N N IPG Photonics Corp. 5493002KZ51CADQ94G15 IPG Photonics Corp. 44980X109 600000.00000000 NS USD 76602000.00000000 1.025697212280 Long EC CORP US N 1 N N N Vicor Corp. 5299005KMQOTR6B51F09 Vicor Corp. 925815102 500000.00000000 NS USD 25025000.00000000 0.335083584466 Long EC CORP US N 1 N N N Nordic Semiconductor ASA 5967007LIEEXZXJGFK95 Nordic Semiconductor ASA N/A 5750358.00000000 NS 36648382.33000000 0.490720132509 Long EC CORP NO N 2 N N N GW Pharmaceuticals PLC 213800ISBN5CNUZMHZ39 GW Pharmaceuticals PLC, ADR 36197T103 100000.00000000 NS USD 11553000.00000000 0.154694131921 Long EC CORP GB N 1 N N N SLM Solutions Group AG 5299004VIBQF63906C97 SLM Solutions Group AG N/A 2000000.00000000 NS 26636485.73000000 0.356661303336 Long EC CORP DE N 2 N N N Fevertree Drinks PLC 2138007AJRLHRVQZLD07 Fevertree Drinks PLC N/A 2000000.00000000 NS 36438527.43000000 0.487910185172 Long EC CORP GB N 2 N N N Aumann AG 529900GLI93PGU71F690 Aumann AG N/A 1000000.00000000 NS 15793071.32000000 0.211468489416 Long EC CORP DE Y 2 N N N Rheon Automatic Machinery Co., Ltd. N/A Rheon Automatic Machinery Co., Ltd. N/A 1000000.00000000 NS 13482473.06000000 0.180529686330 Long EC CORP JP N 2 N N N WANdisco PLC 213800Y1A75RSC698O04 WANdisco PLC N/A 5000000.00000000 NS 29895251.35000000 0.400296023212 Long EC CORP JE N 2 N N N Xaar PLC 213800MXEC3KAOBBPO57 Xaar PLC N/A 4000000.00000000 NS 2055490.04000000 0.027522915901 Long EC CORP GB N 2 N N N THK Co. Ltd. N/A THK Co. Ltd. N/A 2000000.00000000 NS 49829075.17000000 0.667208995749 Long EC CORP JP N 2 N N N Mersen S.A. OQXDLNM5DTBULYMF5U27 Mersen S.A. N/A 1000000.00000000 NS 32806100.44000000 0.439272156955 Long EC CORP FR N 2 N N N Dolby Laboratories, Inc. 549300X04FB2QPCJ5J24 Dolby Laboratories, Inc., Class A 25659T107 800000.00000000 NS USD 55472000.00000000 0.742767496405 Long EC CORP US N 1 N N N Tobii AB 54930045LD4XTJCBGS35 Tobii AB N/A 3000000.00000000 NS 12085941.37000000 0.161830192044 Long EC CORP SE N 2 N N N RaySearch Laboratories AB 549300TYFVYGS0JFWM28 RaySearch Laboratories AB N/A 4000000.00000000 NS 39013480.98000000 0.522388693278 Long EC CORP SE N 2 N N N thyssenkrupp AG 549300UDG16DOYUPR330 thyssenkrupp AG N/A 2000000.00000000 NS 24744345.23000000 0.331325630167 Long EC CORP DE N 2 N N N Jeol Ltd. N/A Jeol Ltd. N/A 2500000.00000000 NS 80632036.13000000 1.079659208363 Long EC CORP JP N 2 N N N H Lundbeck A/S 5493006R4KC2OI5D3470 H Lundbeck A/S N/A 2000000.00000000 NS 84806886.42000000 1.135560259303 Long EC CORP DK N 2 N N N Globant S.A. 2221008DCMSPYS42DS88 Globant S.A. L44385109 300000.00000000 NS USD 36810000.00000000 0.492884185583 Long EC CORP LU N 1 N N N Basler AG 5299006OKY4JQTOWH448 Basler AG N/A 600000.00000000 NS 35772910.13000000 0.478997600526 Long EC CORP DE N 2 N N N Halozyme Therapeutics, Inc. 529900242I3SV9AGM753 Halozyme Therapeutics, Inc. 40637H109 1000000.00000000 NS USD 18980000.00000000 0.254141316011 Long EC CORP US N 1 N N N STMicroelectronics N.V. 213800Z8NOHIKRI42W10 STMicroelectronics N.V. N/A 1000000.00000000 NS 27981725.08000000 0.374673995579 Long EC CORP NL N 2 N N N Genmab A/S 529900MTJPDPE4MHJ122 Genmab A/S N/A 400000.00000000 NS 92488302.29000000 1.238414060043 Long EC CORP DK N 2 N N N Rentokil Initial PLC 549300VN4WV7Z6T14K68 Rentokil Initial PLC N/A 15000000.00000000 NS 92686926.66000000 1.241073631106 Long EC CORP GB N 2 N N N Midsona AB 549300YMDO8YBYYI1981 Midsona AB, Class B N/A 1000000.00000000 NS 5588982.23000000 0.074836211754 Long EC CORP SE N 2 N N N Materialise N.V. 5493004CXYDPCZ5RQK28 Materialise N.V., ADR 57667T100 3100000.00000000 NS USD 56358000.00000000 0.754630995140 Long EC CORP BE N 1 N N N Bavarian Nordic A/S 2138006JCDVYIN6INP51 Bavarian Nordic A/S N/A 1600000.00000000 NS 55719581.00000000 0.746082594464 Long EC CORP DK N 2 N N N Cognex Corp. 549300JQTYZCLC43S226 Cognex Corp. 192422103 1200000.00000000 NS USD 61164000.00000000 0.818983111301 Long EC CORP US N 1 N N N Align Technology, Inc. 549300N5YSE0U3LCP840 Align Technology, Inc. 016255101 200000.00000000 NS USD 51420000.00000000 0.688511405126 Long EC CORP US N 1 N N N Rigel Pharmaceuticals, Inc. 529900KPTNUS5J8K9K66 Rigel Pharmaceuticals, Inc. 766559603 5000000.00000000 NS USD 11300000.00000000 0.151306473705 Long EC CORP US N 1 N N N Mowi ASA 549300W1OGQF5LZIH349 Mowi ASA N/A 4000000.00000000 NS 95466100.60000000 1.278286640723 Long EC CORP NO N 2 N N N Spirax-Sarco Engineering PLC 213800WFVZQMHOZP2W17 Spirax-Sarco Engineering PLC N/A 464285.00000000 NS 54632949.56000000 0.731532650092 Long EC CORP GB N 2 N N N iRobot Corp. 5493009PRNKOUKBAT390 iRobot Corp. 462726100 900000.00000000 NS USD 42345000.00000000 0.566997577792 Long EC CORP US N 1 N N N Rakuten, Inc. 529900IMXUCQKUL1H943 Rakuten, Inc. N/A 6000000.00000000 NS 46533567.77000000 0.623082305150 Long EC CORP JP N 2 N N N Zotefoams PLC 213800B6P256B5XN8D32 Zotefoams PLC N/A 4000000.00000000 NS 22409447.38000000 0.300061456703 Long EC CORP GB N 2 N N N Moncler S.p.A. 815600EBD7FB00525B20 Moncler S.p.A. N/A 1000000.00000000 NS 43181347.34000000 0.578196229721 Long EC CORP IT N 2 N N N 3D Systems Corp. 5493003HHDOCCW4OP744 3D Systems Corp. 88554D205 8000000.00000000 NS USD 87120000.00000000 1.166532742407 Long EC CORP US N 1 N N N FireEye, Inc. 549300E9D2UJUFLLY524 FireEye, Inc. 31816Q101 6000000.00000000 NS USD 95880000.00000000 1.283828734412 Long EC CORP US N 1 N N N Addtech AB 549300QZ5U2IDRHPWL60 Addtech AB, Class B N/A 1000000.00000000 NS 30668196.82000000 0.410645727056 Long EC CORP SE N 2 N N N Boozt AB 549300HOEUKTVLRKQQ57 Boozt AB N/A 3750000.00000000 NS 18178799.38000000 0.243413277025 Long EC CORP SE Y 2 N N N CyberAgent, Inc. 3538006T5KZABPGS8Q08 CyberAgent, Inc. N/A 1600000.00000000 NS 63878496.05000000 0.855330086984 Long EC CORP JP N 2 N N N Manz AG 529900B635NV0KEEOR57 Manz AG N/A 500000.00000000 NS 11452768.35000000 0.153352034796 Long EC CORP DE N 2 N N N Brunello Cucinelli S.p.A. 5493003CX2RZ0FOBH256 Brunello Cucinelli S.p.A. N/A 1500000.00000000 NS 54387537.94000000 0.728246599930 Long EC CORP IT N 2 N N N Gooch & Housego PLC 213800DO3DOOKYOPA952 Gooch & Housego PLC N/A 2000000.00000000 NS 37246660.13000000 0.498731044386 Long EC CORP GB N 2 N N N Acacia Research Corp. 529900BCN7BE6ESPDZ72 Acacia Research Corp. 003881307 2500000.00000000 NS USD 6250000.00000000 0.083687208907 Long EC CORP US N 1 N N N Oncopeptides AB 549300J9WWQ5CBYQ1M77 Oncopeptides AB N/A 2000000.00000000 NS 28706723.45000000 0.384381689986 Long EC CORP SE Y 2 N N N BlackBerry Ltd. 549300HJD8NEGT71RF07 BlackBerry Ltd. 09228F103 4000000.00000000 NS USD 24400000.00000000 0.326714863575 Long EC CORP CA N 1 N N N Rational AG 529900K139N6UFJ1A758 Rational AG N/A 80000.00000000 NS 60256461.13000000 0.806831208100 Long EC CORP DE N 2 N N N Exact Sciences Corp. 549300VM3X1FYD4N9Z14 Exact Sciences Corp. 30063P105 2500000.00000000 NS USD 233200000.00000000 3.122537138767 Long EC CORP US N 1 N N N Nikon Corp. 549300X7LIS9RFELXJ98 Nikon Corp. 654111103 2000000.00000000 NS 24093621.60000000 0.322612471069 Long EC CORP JP N 2 N N N Littelfuse, Inc. 549300MY7HLQFYTPCX75 Littelfuse, Inc. 537008104 400000.00000000 NS USD 70764000.00000000 0.947526664184 Long EC CORP US N 1 N N N Cie Plastic Omnium S.A. 9695001VLC2KYXX0DW73 Cie Plastic Omnium S.A. N/A 1500000.00000000 NS 37700523.91000000 0.504808259262 Long EC CORP FR N 2 N N N 2020-03-23 AIM International Mutual Funds (Invesco International Mutual Funds) Sheri Morris Sheri Morris President XXXX NPORT-EX 2 edgar.htm
Schedule of Investments
January 31, 2020
(Unaudited)
  Shares Value
Common Stocks & Other Equity Interests–97.38%
Argentina–0.49%
Globant S.A.(a) 300,000    $36,810,000
Belgium–1.69%
Biocartis N.V.(a)(b)(c) 6,000,000    37,836,247
Ion Beam Applications(a) 400,000     4,606,316
Materialise N.V., ADR(a)(c) 3,100,000    56,358,000
Umicore S.A. 600,000    27,640,834
      126,441,397
Canada–0.33%
BlackBerry Ltd.(a) 4,000,000    24,400,000
Denmark–3.98%
Bang & Olufsen A/S(a) 2,000,000    11,974,467
Bavarian Nordic A/S(a) 1,600,000    55,719,581
Genmab A/S(a) 400,000    92,488,302
H Lundbeck A/S 2,000,000    84,806,886
Novozymes A/S, Class B 1,000,000    52,195,619
      297,184,855
Finland–0.32%
Rovio Entertainment OYJ(b)(c) 4,700,000    23,630,762
France–2.46%
Adevinta ASA, Class B(a) 900,000    10,942,008
Cie Plastic Omnium S.A. 1,500,000    37,700,524
Mersen S.A. 1,000,000    32,806,101
Rothschild & Co. 229,756     6,176,075
Technicolor S.A.(a)(c) 29,700,000    20,605,836
Teleperformance 300,000    75,400,417
      183,630,961
Germany–6.00%
AIXTRON SE(a) 4,000,000    42,381,586
Aumann AG(b)(c) 1,000,000    15,793,071
Basler AG(c) 600,000    35,772,910
Carl Zeiss Meditec AG, BR 800,000    98,085,664
Continental AG 100,000    11,436,980
Manz AG(a)(c) 500,000    11,452,768
MorphoSys AG(a) 700,000    87,671,135
PVA TePla AG(a)(c) 2,050,000    33,869,820
Rational AG 80,000    60,256,461
SLM Solutions Group AG(a)(c) 2,000,000    26,636,486
thyssenkrupp AG 2,000,000    24,744,345
      448,101,226
Ireland–0.61%
Flutter Entertainment PLC 400,000    45,404,135
Italy–1.99%
Amplifon S.p.A. 1,000,000    28,371,938
Brunello Cucinelli S.p.A. 1,500,000    54,387,538
Freni Brembo S.p.A. 2,000,000    22,856,124
Moncler S.p.A. 1,000,000    43,181,347
      148,796,947
  Shares Value
Japan–10.41%
Comture Corp.(c) 3,000,000    $58,593,257
CyberAgent, Inc. 1,600,000    63,878,496
Disco Corp. 200,000    46,293,795
Jeol Ltd.(c) 2,500,000    80,632,036
M3, Inc. 4,000,000   117,223,512
Nidec Corp. 300,000    37,977,698
Nikon Corp. 2,000,000    24,093,622
Optex Group Co. Ltd.(c) 2,000,000    26,513,938
PeptiDream, Inc.(a) 3,000,000   142,619,303
Rakuten, Inc.(a) 6,000,000    46,533,568
Rheon Automatic Machinery Co. Ltd. 1,000,000    13,482,473
THK Co. Ltd. 2,000,000    49,829,075
Yaskawa Electric Corp. 2,000,000    68,776,842
      776,447,615
Luxembourg–2.17%
Eurofins Scientific SE 300,000   161,628,271
Norway–1.77%
Mowi ASA 4,000,000    95,466,101
Nordic Semiconductor ASA(a) 5,750,358    36,648,382
      132,114,483
Sweden–4.40%
Addtech AB, Class B 1,000,000    30,668,197
Beijer Ref AB 2,000,000    60,117,591
Boozt AB(a)(b)(c) 3,750,000    18,178,799
Hansa Biopharma AB(a) 1,938,841    14,470,610
Indutrade AB 2,000,000    71,934,341
Midsona AB, Class B 1,000,000     5,588,982
Oncopeptides AB(a)(b) 2,000,000    28,706,724
RaySearch Laboratories AB(a)(c) 4,000,000    39,013,481
Recipharm AB, Class B 2,000,000    29,315,932
Tobii AB(a) 3,000,000    12,085,941
Xvivo Perfusion AB(a) 1,000,000    18,114,129
      328,194,727
Switzerland–0.45%
GeNeuro S.A.(a)(c) 1,661,017     5,434,343
STMicroelectronics N.V. 1,000,000    27,981,725
      33,416,068
United Kingdom–12.38%
Allied Minds PLC 10,000,000     4,850,605
AO World PLC(a) 20,000,000    20,124,972
ASOS PLC(a) 700,000    28,386,041
Aston Martin Lagonda Global Holdings PLC(a)(b)(c) 20,500,000   135,493,298
Blue Prism Group PLC(a) 3,000,000    69,206,691
boohoo Group PLC(a) 30,000,000   119,708,077
EVR Holdings PLC(a) 68,750,000     4,041,902
Fevertree Drinks PLC 2,000,000    36,438,527
First Derivatives PLC 1,200,000    43,942,486
Frontier Developments PLC(a)(c) 3,000,000    55,963,275
Gooch & Housego PLC(c) 2,000,000    37,246,660
GW Pharmaceuticals PLC, ADR(a) 100,000    11,553,000
 
See accompanying notes which are an integral part of this schedule.
Invesco Oppenheimer Global Opportunities Fund
  Shares Value
United Kingdom–(continued)
IG Group Holdings PLC 3,000,000    $26,284,545
IP Group PLC(a) 20,785,545    19,049,146
IQE PLC(a)(c) 140,000,000    94,722,015
M&C Saatchi PLC(c) 6,600,000     8,681,222
Rentokil Initial PLC 15,000,000    92,686,927
Spirax-Sarco Engineering PLC 464,285    54,632,950
WANdisco PLC(a)(c) 5,000,000    29,895,252
Xaar PLC(c) 4,000,000     2,055,490
Zoo Digital Group PLC(a)(c) 7,000,000     6,697,322
Zotefoams PLC(c) 4,000,000    22,409,447
      924,069,850
United States–47.93%
3D Systems Corp.(a)(c) 8,000,000    87,120,000
Acacia Research Corp.(a) 2,500,000     6,250,000
Advanced Micro Devices, Inc.(a) 14,000,000   658,000,000
Align Technology, Inc.(a) 200,000    51,420,000
Applied Materials, Inc. 1,000,000    57,990,000
Arrowhead Pharmaceuticals, Inc.(a) 3,000,000   125,730,000
Cloudera, Inc.(a) 8,220,000    84,583,800
Cognex Corp. 1,200,000    61,164,000
Coherent, Inc.(a) 600,000    84,858,000
Corning, Inc. 1,000,000    26,690,000
Cree, Inc.(a) 1,000,000    46,490,000
Dolby Laboratories, Inc., Class A 800,000    55,472,000
Exact Sciences Corp.(a) 2,500,000   233,200,000
FireEye, Inc.(a) 6,000,000    95,880,000
First Solar, Inc.(a) 2,000,000    99,160,000
Halozyme Therapeutics, Inc.(a) 1,000,000    18,980,000
Illumina, Inc.(a) 200,000    58,014,000
  Shares Value
United States–(continued)
IPG Photonics Corp.(a) 600,000    $76,602,000
iRobot Corp.(a) 900,000    42,345,000
Littelfuse, Inc. 400,000    70,764,000
Manhattan Associates, Inc.(a) 600,000    51,276,000
Nektar Therapeutics(a)(c) 31,300,000   622,557,000
Nevro Corp.(a) 1,000,000   132,910,000
ON Semiconductor Corp.(a) 2,000,000    46,300,000
PDF Solutions, Inc.(a)(c) 3,000,000    47,280,000
PTC, Inc.(a) 1,200,000    99,744,000
QUALCOMM, Inc. 2,000,000   170,620,000
Rigel Pharmaceuticals, Inc.(a) 5,000,000    11,300,000
Rite Aid Corp.(a) 2,500,000    29,875,000
Rollins, Inc. 1,500,000    56,925,000
Shake Shack, Inc., Class A(a) 1,000,000    67,450,000
Twitter, Inc.(a) 2,000,000    64,960,000
Veeco Instruments, Inc.(a)(c) 4,000,000    51,000,000
Vicor Corp.(a) 500,000    25,025,000
Xeris Pharmaceuticals, Inc.(a) 1,000,000     6,370,000
Zendesk, Inc.(a) 600,000    51,840,000
      3,576,144,800
Total Common Stocks & Other Equity Interests (Cost $5,941,793,954) 7,266,416,097
Money Market Funds–2.71%
Invesco Government & Agency Portfolio, Institutional Class, 1.48%(d) 201,709,220   201,709,220
TOTAL INVESTMENTS IN SECURITIES—100.09% (Cost $6,143,503,174) 7,468,125,317
OTHER ASSETS LESS LIABILITIES–(0.09)% (6,441,531)
NET ASSETS–100.00% $7,461,683,786
Investment Abbreviations:
ADR – American Depositary Receipt
BR – Bearer Shares
See accompanying notes which are an integral part of this schedule.
Invesco Oppenheimer Global Opportunities Fund
Notes to Schedule of Investments:
(a) Non-income producing security.
(b) Security purchased or received in a transaction exempt from registration under the Securities Act of 1933, as amended (the “1933 Act”). The security may be resold pursuant to an exemption from registration under the 1933 Act, typically to qualified institutional buyers. The aggregate value of these securities at January 31, 2020 was $259,638,901, which represented 3.48% of the Fund’s Net Assets.
(c) The Investment Company Act of 1940 as amended (the “1940 Act”), defines “affiliated person” to include an issuer of which a fund holds 5% or more of the outstanding voting securities. The Fund has not owned enough to the outstanding voting securities of the issuer to have control (as defined in the 1940 Act) of that issuer. The table below shows the Fund’s transactions in, and earnings from, its investments in affiliates (excluding affiliated money market funds) for the three months ended January 31, 2020.
    
  Value
October 31, 2019 		Purchases
at Cost 		Proceeds
from Sales 		Change in
Unrealized
Appreciation
(Depreciation) 		Realized
Gain 		Value
January 31, 2020 		Dividend
Income
3D Systems Corp. $75,920,000 $- $- $11,200,000 $- $87,120,000 $-
Aston Martin Lagonda Global Holdings PLC - 63,100,878 - 72,392,420 - 135,493,298 -
Aumann AG 13,351,769 - - 2,441,302 - 15,793,071 -
Basler AG 30,938,468 - - 4,834,442 - 35,772,910 -
Biocartis N.V. 21,488,283 19,106,968 - (2,759,004) - 37,836,247 -
Boozt AB 25,006,956 - - (6,828,157) - 18,178,799 -
Comture Corp. 56,920,881 - - 1,672,376 - 58,593,257 178,873
Frontier Developments PLC 42,523,380 - - 13,439,895 - 55,963,275 -
GeNeuro S.A. - 5,434,343 - - - 5,434,343 -
Gooch & Housego PLC 28,894,340 - - 8,352,320 - 37,246,660 188,798
IQE PLC 67,965,522 43,617,191 - (16,860,698) - 94,722,015 -
Jeol Ltd. 66,229,962 - - 14,402,074 - 80,632,036 -
M&C Saatchi PLC - 6,982,693 - 1,698,529 - 8,681,222 -
Manz AG 10,687,288 - - 765,480 - 11,452,768 -
Materialise N.V. - 51,708,000 - 4,650,000 - 56,358,000 -
Nektar Therapeutics 536,012,500 - - 86,544,500 - 622,557,000 -
Optex Group Co. Ltd. 30,597,058 - - (4,083,120) - 26,513,938 246,621
PDF Solutions, Inc. 48,480,000 - - (1,200,000) - 47,280,000 -
PVA TePla AG 24,334,731 - - 9,535,089 - 33,869,820 -
RaySearch Laboratories AB 24,085,284 28,275,261 - (13,347,064) - 39,013,481 -
Rovio Entertainment OYJ 21,096,633 - - 2,534,129 - 23,630,762 -
SLM Solutions Group AG 17,981,027 17,081,772 - (8,426,313) - 26,636,486 -
Technicolor S.A. 24,799,848 - - (4,194,012) - 20,605,836 -
Veeco Instruments, Inc. 54,560,000 - - (3,560,000) - 51,000,000 -
WANdisco PLC 16,337,599 8,968,272 - 4,589,381 - 29,895,252 -
Xaar PLC 2,456,756 - - (401,266) - 2,055,490 -
Zoo Digital Group PLC 7,813,467 - - (1,116,145) - 6,697,322 -
Zotefoams PLC - 23,164,974 - (755,527) - 22,409,447 -
Total $1,248,481,752 $267,440,352 $- $175,520,631 $- $1,691,442,735 $614,292
    
(d) The money market fund and the Fund are affiliated by having the same investment adviser. The rate shown is the 7-day SEC standardized yield as of January 31, 2020.
The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.
See accompanying notes which are an integral part of this schedule.
Invesco Oppenheimer Global Opportunities Fund
Notes to Quarterly Schedule of Portfolio Holdings
January 31, 2020
(Unaudited)
NOTE 1—Additional Valuation Information
Generally Accepted Accounting Principles ("GAAP") defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, under current market conditions. GAAP establishes a hierarchy that prioritizes the inputs to valuation methods, giving the highest priority to readily available unadjusted quoted prices in an active market for identical assets (Level 1) and the lowest priority to significant unobservable inputs (Level 3), generally when market prices are not readily available or are unreliable. Based on the valuation inputs, the securities or other investments are tiered into one of three levels. Changes in valuation methods may result in transfers in or out of an investment’s assigned level:
Level 1 — Prices are determined using quoted prices in an active market for identical assets.
Level 2 — Prices are determined using other significant observable inputs. Observable inputs are inputs that other market participants may use in pricing a security. These may include quoted prices for similar securities, interest rates, prepayment speeds, credit risk, yield curves, loss severities, default rates, discount rates, volatilities and others.
Level 3 — Prices are determined using significant unobservable inputs. In situations where quoted prices or observable inputs are unavailable (for example, when there is little or no market activity for an investment at the end of the period), unobservable inputs may be used. Unobservable inputs reflect the Fund’s own assumptions about the factors market participants would use in determining fair value of the securities or instruments and would be based on the best available information.
The following is a summary of the tiered valuation input levels, as of January 31, 2020. The level assigned to the securities valuations may not be an indication of the risk or liquidity associated with investing in those securities. Because of the inherent uncertainties of valuation, the values reflected in the financial statements may materially differ from the value received upon actual sale of those investments.
  Level 1 Level 2 Level 3 Total
Investments in Securities        
Argentina $36,810,000 $— $— $36,810,000
Belgium 56,358,000 70,083,397 — 126,441,397
Canada 24,400,000 — — 24,400,000
Denmark — 297,184,855 — 297,184,855
Finland — 23,630,762 — 23,630,762
France — 183,630,961 — 183,630,961
Germany — 448,101,226 — 448,101,226
Ireland — 45,404,135 — 45,404,135
Italy — 148,796,947 — 148,796,947
Japan — 776,447,615 — 776,447,615
Luxembourg — 161,628,271 — 161,628,271
Norway — 132,114,483 — 132,114,483
Sweden — 328,194,727 — 328,194,727
Switzerland 5,434,343 27,981,725 — 33,416,068
United Kingdom 11,553,000 912,516,850 — 924,069,850
United States 3,576,144,800 — — 3,576,144,800
Money Market Funds 201,709,220 — — 201,709,220
Total Investments $3,912,409,363 $3,555,715,954 $— $7,468,125,317
NOTE 2—Subsequent Event
The World Health Organization has declared the coronavirus (COVID-19) to be a public health emergency. COVID-19 has led to increased short-term market volatility and may have adverse long-term effects on U.S. and world economies and markets in general. COVID-19 may adversely impact the Fund’s ability to achieve its investment objective, as stated in the most recent shareholder report. Because of the uncertainties on valuation, the global economy and business operations, values reflected in the Schedule of Investments may materially differ from the value received upon actual sales of those investments.
Invesco Oppenheimer Global Opportunities Fund